Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.
Sato A, Tamura Y, Sato N, Yamashita T, Takada T, Sato M, Osai Y, Okura M, Ono I, Ito A, Honda H, Wakamatsu K, Ito S, Jimbow K. Sato A, et al. Among authors: jimbow k. Cancer Sci. 2010 Sep;101(9):1939-46. doi: 10.1111/j.1349-7006.2010.01623.x. Cancer Sci. 2010. PMID: 20594194 Free article.
N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.
Sato M, Yamashita T, Ohkura M, Osai Y, Sato A, Takada T, Matsusaka H, Ono I, Tamura Y, Sato N, Sasaki Y, Ito A, Honda H, Wakamatsu K, Ito S, Jimbow K. Sato M, et al. Among authors: jimbow k. J Invest Dermatol. 2009 Sep;129(9):2233-41. doi: 10.1038/jid.2009.39. Epub 2009 Mar 19. J Invest Dermatol. 2009. PMID: 19295615 Free article.
Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.
Takada T, Yamashita T, Sato M, Sato A, Ono I, Tamura Y, Sato N, Miyamoto A, Ito A, Honda H, Wakamatsu K, Ito S, Jimbow K. Takada T, et al. Among authors: jimbow k. J Biomed Biotechnol. 2009;2009:457936. doi: 10.1155/2009/457936. Epub 2009 Oct 8. J Biomed Biotechnol. 2009. PMID: 19830247 Free PMC article.
Melanoma-Targeted Chemothermotherapy and In Situ Peptide Immunotherapy through HSP Production by Using Melanogenesis Substrate, NPrCAP, and Magnetite Nanoparticles.
Jimbow K, Ishii-Osai Y, Ito S, Tamura Y, Ito A, Yoneta A, Kamiya T, Yamashita T, Honda H, Wakamatsu K, Murase K, Nohara S, Nakayama E, Hasegawa T, Yamamoto I, Kobayashi T. Jimbow K, et al. J Skin Cancer. 2013;2013:742925. doi: 10.1155/2013/742925. Epub 2013 Feb 21. J Skin Cancer. 2013. PMID: 23533767 Free PMC article.
251 results